“PRRT: What We Know, Special Considerations & Clinical Trials“ with Dr. Strosberg • Jan 11, 2024
Learn the latest on PRRT with NET expert Dr. Jonathan Strosberg. Dr Strosberg was the principal investigator of the NETTER-1 study which led to the FDA approval of Lutathera and has authored numerous articles on PRRT. He will discuss the latest in PRRT, including special considerations and current clinical trials.
Visit for more information.
1 view
405
97
3 months ago 01:23:41 1
Education Webinar Series - Clinical Trials: Open and Recruiting
8 months ago 01:29:29 1
Recent International Guidelines on the Management of ... SDH Pathogenic Variants
9 months ago 00:02:37 1
Chief Keef & Lil Yachty - Say Ya Grace (Lyrics)
10 months ago 01:56:53 3
2-HOUR STUDY WITH ME🌦️ / calm piano / A Rainy Day in Shibuya, Tokyo / with countdown+alarm
10 months ago 01:12:47 1
“PRRT: What We Know, Special Considerations & Clinical Trials“ with Dr. Strosberg • Jan 11, 2024
11 months ago 02:01:41 1
Fourth Annual Fireside Chat Ask the Doc
1 year ago 00:58:26 1
Special Informational Webinar - After AZEDRA: Moving Forward Together
1 year ago 01:01:14 1
Educational Webinar Series -- Five Years Since Azedra FDA Approval: What Have We Learned?
2 years ago 01:28:20 2
LACNETS • “What’s New in PRRT“ with Dr. Amir Iravani • Apr 2023
2 years ago 01:56:53 12
2-HOUR STUDY WITH ME🌦️ / rain sound / A Rainy Day in Shibuya, Tokyo / with countdown+alarm
3 years ago 04:39:02 5
Know Your NETs 2021 Virtual Conference for NET Patients and Caregivers
4 years ago 00:10:11 2
Peptide Receptor Radionuclide Therapy (PRRT)
5 years ago 00:24:06 10
Nuclear medicine for NETs, Lisa Bodei, MD, Memorial Sloan Kettering